| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/14/2005 | US20050152897 Methods for inducing T cell tolerance to a tissue or organ graft |
| 07/14/2005 | US20050152896 Anti-galanin antibodies and uses thereof |
| 07/14/2005 | US20050152893 Methods and materials for the inhibition of transplant rejection |
| 07/14/2005 | US20050152878 Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases |
| 07/14/2005 | US20050152874 Unblocking immunization at a regional lymph node by: promoting differentiation and maturation of immature dendritic cells in a regional lymph node and; allowing presentation by resulting mature dendritic cells of antigen to T-cells |
| 07/14/2005 | US20050152873 Containing an immunogen, a first adjuvant functioning as a directing molecule and a second adjuvant functioning as a stimulant which are chemically distinct |
| 07/14/2005 | US20050152837 Novel method of diagnosing, monitoring, staging, imaging and treating cancer |
| 07/14/2005 | DE10018681B4 Therapeutisches Mittel für die autologe Immuntherapie von Tumoren sowie Verfahren zur Herstellung eines solchen Mittels A therapeutic agent for autologous immunotherapy of tumors as well as methods for preparing such an agent |
| 07/14/2005 | CA2704300A1 Cd40 antibody formulation and methods |
| 07/14/2005 | CA2592504A1 Classification of cancer |
| 07/14/2005 | CA2552271A1 Proteoliposomes and its derivatives as adjuvants inducers of citotoxic response and the resultant formulations |
| 07/14/2005 | CA2552155A1 Use of il-18 binding protein in inflammations |
| 07/14/2005 | CA2551696A1 Immunopotentiator and method of enhancing immunoactivity using the same |
| 07/14/2005 | CA2551560A1 Antibodies for oncogenic strains of hpv and methods of their use |
| 07/14/2005 | CA2551553A1 Modulation of 5-ht2 receptors as a treatment for cardiovascular diseases |
| 07/14/2005 | CA2551489A1 Multi plasmid system for the production of influenza virus |
| 07/14/2005 | CA2551110A1 Treatment of cancer with novel anti-il 13 monoclonal antibodies |
| 07/14/2005 | CA2551097A1 Agonist anti-trkc antibodies and methods using same |
| 07/14/2005 | CA2551008A1 Anti-cd40 antibody mutants |
| 07/14/2005 | CA2550998A1 Use of fc receptor polymorphisms as diagnostics for treatment strategies for immune-response disorders |
| 07/14/2005 | CA2550996A1 Methods for generating multimeric molecules |
| 07/14/2005 | CA2550927A1 A gram negative bacterium with reduced lps level in the outer membrane and use thereof for treating gram negative bacterial infection |
| 07/14/2005 | CA2550923A1 Combination vaccine for poultry |
| 07/14/2005 | CA2550651A1 Novel anti-il 13 antibodies and uses thereof |
| 07/14/2005 | CA2550455A1 Haemophilus influenzae type iv pili |
| 07/14/2005 | CA2550356A1 Heh4 molecules and uses thereof |
| 07/14/2005 | CA2549652A1 Cd40 antibody formulation and methods |
| 07/14/2005 | CA2548947A1 Anti-cd52 antibody treatment for diabetes |
| 07/14/2005 | CA2548181A1 Anti-retroviral agents, compositions, methods and uses |
| 07/14/2005 | CA2544893A1 Synergistic liposomal adjuvants |
| 07/14/2005 | CA2541135A1 Methods and kits for predicting an infectious disease state |
| 07/13/2005 | EP1553414A1 Methods for the diagnosis and treatment of metastatic prostate tumors |
| 07/13/2005 | EP1553182A2 Regulated genes and uses thereof |
| 07/13/2005 | EP1553169A1 Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics |
| 07/13/2005 | EP1553168A2 Methods for selectively stimulating proliferation of T cells |
| 07/13/2005 | EP1552848A1 Compositions against chicken coccidiosis |
| 07/13/2005 | EP1552846A2 Use of heparinases to decrease inflammatory responses |
| 07/13/2005 | EP1552462A1 Methods of treating and preventing colitis involving il-13 and nk-t cells |
| 07/13/2005 | EP1552023A2 Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors |
| 07/13/2005 | EP1552016A2 Methods for vaccine identification and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of the herpesvirus family |
| 07/13/2005 | EP1551990A2 Diagnosis and treatment of chemoresistant tumors |
| 07/13/2005 | EP1551979A2 Compositions and methods for treatment and detection of multiple cancers |
| 07/13/2005 | EP1551974A1 Vector system |
| 07/13/2005 | EP1551963A1 Improved immunotherapy |
| 07/13/2005 | EP1551961A2 Methods of treating and preventing neurological symptoms caused by avian reovirus and novel associated characteristics |
| 07/13/2005 | EP1551960A2 Hepatitis c viral-like particle purification |
| 07/13/2005 | EP1551955A2 Methods of implanting mesenchymal stem cells for tissue repair and formation |
| 07/13/2005 | EP1551927A1 Biological active coating components, coatings, and coated surfaces |
| 07/13/2005 | EP1551877A2 Taci antibodies and uses thereof |
| 07/13/2005 | EP1551875A2 Buffered formulations for concentrating antibodies and methods of use thereof |
| 07/13/2005 | EP1551869A2 Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof |
| 07/13/2005 | EP1551867A2 Use of poly-alpha2,8-sialic acid mimetic peptides to modulate ncam functions |
| 07/13/2005 | EP1551812A2 Mitotic kinesin inhibitors |
| 07/13/2005 | EP1551790A2 Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof |
| 07/13/2005 | EP1551461A2 Azo compounds for type i phototherapy |
| 07/13/2005 | EP1551459A1 Microbubble compositions, and methods for preparing and using same |
| 07/13/2005 | EP1551452A1 Compositions and methods for therapeutic treatment |
| 07/13/2005 | EP1551451A2 Use of escherichia coli heat labile toxin as an adjuvant in birds and poultry |
| 07/13/2005 | EP1551449A1 Reagents and methods for engaging unique clonotypic lymphocyte receptors |
| 07/13/2005 | EP1551448A2 Targeted cd1d molecules |
| 07/13/2005 | EP1551446A1 Neuroendocrine marker for cancer and method for producing same |
| 07/13/2005 | EP1551445A2 Use of il-2 receptor antibodies to prevent toxicity associated with amphotericin b antimycotic therapy |
| 07/13/2005 | EP1551434A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 07/13/2005 | EP1551376A2 Immunomodulatory compositions, methods of making, and methods of use thereof |
| 07/13/2005 | EP1551357A2 Group b streptococcus vaccine |
| 07/13/2005 | EP1551225A2 Cryopreservation of haptenized tumor cells |
| 07/13/2005 | EP1551221A2 Nucleic acid compositions for stimulating immune responses |
| 07/13/2005 | EP0698099B1 Method for the culture in vitro of different stages of tissue parasites |
| 07/13/2005 | CN1639569A Methods and compositions for inducing an immune response |
| 07/13/2005 | CN1639331A Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives |
| 07/13/2005 | CN1639324A Viral variants with altered susceptibility to nucleoside analogs and uses thereof |
| 07/13/2005 | CN1639323A Vesicles derived from T cells, production and uses |
| 07/13/2005 | CN1639322A Recombinant spores |
| 07/13/2005 | CN1639321A Bacterial spores |
| 07/13/2005 | CN1639317A Probiotic lactobacillus salivarius strains |
| 07/13/2005 | CN1639195A Selective targeting of tumor vasculature using antibody molecules |
| 07/13/2005 | CN1639194A Antibodies against cancer |
| 07/13/2005 | CN1639193A Antibodies against fibroblast growth factor 23 |
| 07/13/2005 | CN1639192A Anti-human tenascin monoclonal antibody |
| 07/13/2005 | CN1639191A 鼠李糖结合蛋白 Rhamnose-binding protein |
| 07/13/2005 | CN1639185A Cancer-associated epitope |
| 07/13/2005 | CN1638808A Coupling proteins to a modified polysaccharide |
| 07/13/2005 | CN1638807A Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy |
| 07/13/2005 | CN1638800A Human monoclonal antibodies against CD30 |
| 07/13/2005 | CN1638799A Human mast cell-expressed membrane proteins |
| 07/13/2005 | CN1638798A Antibody-containing solution pharmaceuticals |
| 07/13/2005 | CN1638797A Cancer treatment |
| 07/13/2005 | CN1638796A Methods of administering anti-TNF alpha antibodies |
| 07/13/2005 | CN1638795A MVA expressing modified HIV envelope, GAG, and pol genes |
| 07/13/2005 | CN1638794A Glycoconjugate vaccines for use in immune-compromised populations |
| 07/13/2005 | CN1638792A FGFR agonists |
| 07/13/2005 | CN1638789A Methods of treating disorders of the eye and surrounding tissue with thymosin beta4 (t beta 4), analogues, isoforms and other derivatives |
| 07/13/2005 | CN1638780A Methods for particle-assisted polynucleotide immunization using a pulsed electric field |
| 07/13/2005 | CN1638640A Human fetal bladder-derived epithelial cells |
| 07/13/2005 | CN1637135A Attenuated eel vibrio strain and its application |
| 07/13/2005 | CN1637013A Modified cpg oligodeoxynucleotide with improved immunoregulatory function |
| 07/13/2005 | CN1636596A Composition for reducing viral infection rate of crustacean and application method thereof |
| 07/13/2005 | CN1210401C Compound from moraxella catarrhalis |
| 07/13/2005 | CN1210309C Anti-idiotype monoclonal antibodies, their use in active immunotherapy of malignant tumors and compositions containing them |
| 07/13/2005 | CN1210308C Humanized anti-HER2 monoclonal antibody, its preparation method and pharmaceutical composition thereof |